3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Anatomic Stage III Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Renal Insufficiency, Chronic
1
Prostatic Neoplasms
1
Pleuropulmonary blastoma
1
Pain
1
Neuroblastoma
1
Melanoma
1
Leukemia, Hairy Cell
1
Ganglioneuroblastoma
1
Dupuytren Contracture
1
Carcinoma, Renal Cell
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Interventions
fludarabine
10
ruxolitinib
9
fludarabine phosphate
9
Whole-Body Irradiation
9
Specimen Handling
9
Cyclophosphamide
8
Azacitidine
8
Mycophenolic Acid
7
Cytarabine
7
Busulfan
7
Biopsy
7
Tacrolimus
6
venetoclax
5
Stem Cell Transplantation
5
Sirolimus
5
Peripheral Blood Stem Cell Transplantation
5
Injections
5
Granulocyte Colony-Stimulating Factor
5
Melphalan
4
Cyclosporine
4
CPX-351
4
luspatercept
3
ivosidenib
3
decitabine and cedazuridine drug combination
3
Thiotepa
3
Methotrexate
3
Liposomes
3
Idarubicin
3
Daunorubicin
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
High-Energy Shock Waves
×
90 days
×
Clear all
No trials found.